PROTOXIN is developed by Protox Inc..

What development phase is PROTOXIN in?

PROTOXIN is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

PROTOXIN

Protox Inc. · FDA-approved active Biologic Quality 4/100

At a glance

Generic name	PROTOXIN
Sponsor	Protox Inc.
Modality	Biologic
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines (PHASE3)
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines (PHASE3)
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines (PHASE1,PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PROTOXIN CI brief — competitive landscape report
PROTOXIN updates RSS · CI watch RSS
Protox Inc. portfolio CI